Lexeo Therapeutics, Inc. Common StockLXEONASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank80
3Y CAGR+59.2%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+59.2%/yr
Annual compound
Percentile
P80
Within normal range
vs 3Y Ago
4x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$5.34M-29.3%
2024$7.56M+163.6%
2023$2.87M+116.4%
2022$1.32M+8733.3%
2021$15000.00-
2020$0.00-